ASHLEY SALTER-GREEN: Open Payments
NPI 1538586326 · CLOVIS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,092 in 57 payments from 27 companies in 2025. Trend: 2023 $1,031 · 2024 $994 · 2025 $1,092
Food & beverage: $1,092
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $243 |
| PFIZER INC. | 6 | $120 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $73 |
| AstraZeneca Pharmaceuticals LP | 3 | $72 |
| Novo Nordisk Inc | 3 | $68 |
| SANOFI-AVENTIS U.S. LLC | 2 | $44 |
| Supernus Pharmaceuticals, Inc. | 2 | $37 |
| Lilly USA, LLC | 2 | $34 |
| Radius Health, Inc. | 1 | $28 |
| Antares Pharma, Inc. | 1 | $28 |
Products named: NURTEC ODT, VRAYLAR, AIRSUPRA, UBRELVY, JARDIANCE, QULIPTA, Ozempic, TZIELD.
Industry payments across CA — which companies pay providers there.
